PO.TB10.06 · 肿瘤生物学

在同一组织切片上使用原位合成测序和空间蛋白检测对T细胞受体进行亚细胞分辨率的空间表征

Spatial characterization, of T-cell receptors at subcellular resolution using in situ sequencing-by-synthesis and spatial protein detection on the same tissue section

编号 817 展板 29 时间 4/19 02:00–05:00 区域 Section 32 主讲 Hansueli Meyer, MS
分会场 Spatial Protein Profiling and Multi-Modal Mapping of Tumor and Circulating Ecosystems
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Hansueli Meyer1, Robert Pinard1, Ryan Hindman2, Emily Neil1, Chris Nehme1, Sameh Soliman1, Dongju Park1, Rebecca C. Hennessey1, Jinling Wang1, Alex Makrigiorgos1, John Lee1, Seiyu Hosono1, Matthias Wahl3, Dominic Mangiardi1, Mong Marma1, Hsu-yi Lee1, Andreas Bosio3

1Miltenyi Biotec, Waltham, MA,2Miltenyi Biotec, Gaithersburg, MD,3Miltenyi Biotec, Bergisch-Gladbach, Germany

摘要 Abstract

中文摘要
摘要:基于蛋白和RNA表达并结合RNA测序来分析肿瘤微环境(TME)及其免疫背景,为理解肿瘤生物学、预测治疗反应及指导个性化治疗的开发提供了一种强有力的方法。它提供了对肿瘤生物学以及遗传改变、细胞环境和免疫反应之间相互作用更全面的理解。目前,市售的空间转录组学方法需要在组织上进行cDNA条形码标记,并在单独的仪器上进行离体cDNA测序,这限制了直接在原位对已知或未知区域(如T细胞或B细胞受体(TCR/BCR)的互补决定区)进行测序的能力。这一局限可能影响对组织内免疫反应的详细分析。需要技术进步以实现直接原位测序,从而获得更全面的洞见。 在此,我们提出一种新方法,将原位合成测序与高重数蛋白检测(30+)、H&E和DAPI相结合——所有操作均在同一福尔马林固定石蜡包埋(FFPE)切片上进行。该技术基于对滚环扩增RNA检测探针和直接偶联抗体的蛋白进行迭代检测,并且还能够对已知和未知RNA序列进行原位四色合成测序(SBS)分析。已知RNA转录本和未知RNA序列的检测可与Miltenyi Biotec现成的、经预先测试、即用型MICS抗体相结合,以在同一FFPE组织切片上识别蛋白。 利用这一新方法,我们生成了能够在空间背景下详细表征TCR的数据。将5至10 μm厚的肿瘤FFPE切片转移至载玻片,随后进行脱蜡和抗原修复。原位测序与Miltenyi Biotec的MICS抗体的广泛组合以及DAPI成像同时进行,随后在同一FFPE组织切片上进行H&E染色。 我们观察到高度多样的克隆型,将其分配到T细胞亚型并用于生成克隆型图谱。同时也识别出同一细胞内共定位的α链和β链受体。我们进一步应用免疫细胞蛋白标志物,在复杂的组织环境中进行分割和定位。我们的方法使研究人员能够基于T细胞群独特的受体序列识别和分析其多样性,同时直接在组织上对免疫细胞克隆性进行空间定位。这种非破坏性方法将组织保留在其原始背景中。
查看英文原文 English abstract
Abstract: Analyzing the tumor microenvironment (TME) and its immune context based on protein and RNA expression, alongside RNA sequencing, offers a powerful approach to understand tumor biology, predict treatment response, and guide the development of personalized therapies. It provides a more comprehensive understanding of tumor biology and the interplay between genetic alterations, cellular environment, and immune response. Currently, commercially available spatial transcriptomics methods require cDNA barcoding on tissue and ex situ cDNA sequencing on a separate instrument which limits the ability to directly sequence known or unknown regions in situ, such as T-cell or B-cell receptor (TCR/BCR) complementarity determining regions. This limitation can impact the detailed analysis of immune responses within tissue. Advances in technology are needed to enable direct in situ sequencing for more comprehensive insights. Here, we present a novel approach combining in situ sequencing-by-synthesis with high-plex protein detection (30+), H&E, and DAPI - all performed on the same formalin-fixed, paraffin-embedded section. The technology is based on iterative detection of rolling circle amplified RNAs detection probes, proteins with directly conjugated antibodies and is also capable of in situ four color-based sequencing-by-synthesis (SBS) analysis of known and unknown RNA sequences. The detection of known RNA transcripts and unknown RNA sequences can be combined with existing pre-tested, ready to use MICS antibodies by Miltenyi Biotec, to identify proteins on the same FFPE tissue section. Using this novel approach we generated data that enabled detailed characterization of TCRs in their spatial context. Five to ten µm thick tumor FFPE sections were transferred to glass slides, followed by deparaffinization and antigen retrieval. In situ sequencing was concurrently combined with an extensive panel of Miltenyi Biotec's MICS antibodies and DAPI imaging, followed by H&E staining on the same FFPE tissue section . We observed high diversity of clonotypes which were assigned to T-cell subtypes and used to generate clonotype maps. Co-localized alpha and beta chain receptors within the same cell were identified as well. We also further applied immune cell protein markers for segmentation and mapping in the complex tissue environment. Our approach enables researchers to identify and analyze the diversity of T-Cell populations based on their unique receptor sequences, while spatially mapping immune cell clonality directly on tissue. This nondestructive method preserves the tissue in its original context.
利益披露 Disclosure
H. Meyer, Miltenyi Biotec Employment. R. Pinard, Miltenyi Biotec Employment. R. Hindman, Miltenyi Biotec Employment. E. Neil, Miltenyi Biotec Employment. C. Nehme, Miltenyi Biotec Employment. S. Soliman, Miltenyi Biotec Employment. D. Park, Miltenyi Biotec Employment. R. C. Hennessey, Miltenyi Biotec Employment. J. Wang, Miltenyi Biotec Employment. A. Makrigiorgos, Miltenyi Biotec Employment. J. Lee, Miltenyi Biotec Employment. S. Hosono, Miltenyi Biotec Employment. M. Wahl, Miltenyi Biotec Employment. D. Mangiardi, Miltenyi Biotec Employment. M. Marma, Miltenyi Biotec Employment. H. Lee, Miltenyi Biotec Employment. A. Bosio, Miltenyi Biotec Employment.

← 返回 AACR 2026 检索